With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Fox News contributor Dr. Marty Makary cleared the final hurdle to a final confirmation vote on Tuesday, inching closer to ...

Yet today, at what should be a celebration of this revolutionary technology’s potential, we find ourselves wondering about the future of mRNA research. The scientific community is watching if funding ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

"We were privileged and lucky enough that we could do something." Three women who were involved in the development of the ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' ...

Pfizer is trading like it caught a cold, despite showing strong financial health post-COVID. In Q4 2024, Pfizer raked in ...